# Citicoline as Neuroprotector in Neonates Exposed to Hypoxia

> **NCT03949049** · PHASE3 · RECRUITING · sponsor: **Sherief Abd-Elsalam** · enrollment: 40 (estimated)

## Conditions studied

- Neonatal Hypoxia

## Interventions

- **DRUG:** Citicoline
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03949049
- **Lead sponsor:** Sherief Abd-Elsalam
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-02-01
- **Primary completion:** 2029-12-01
- **Final completion:** 2029-12-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2019-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03949049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03949049, "Citicoline as Neuroprotector in Neonates Exposed to Hypoxia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03949049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*